Downregulated CDK10 promotes cancer progression and radioresistance in lung cancer through activating the JNK/c-Jun signaling pathway

Lung cancer is one of the most significant malignancies, with both high morbidity and mortality.CDK10 is closely related to cancer progression and metastasis.However, its role in lung cancer radioresistance demands further clarification.In this study, we demonstrated that CDK10 was downregulated in lung cancer tissues, and CDK10 expression level was associated with the clinical prognosis in lung cancer patients.We also found that silencing CDK10 promoted lung cancer cell proliferation, migration, and radioresistance.We further verified that silencing CDK10 facilitated the activation of JNK/c-Jun signaling, and c-Jun depletion could reverse the effects of CDK10 knockdown in lung cancer cells.Our findings revealed that CDK10 plays an important role in cell growth and radioresistance by inhibiting JNK/c-Jun signaling pathway in lung cancer.Therefore, CDK10 might be a promising therapeutic target in lung cancer.[